跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,897 条关于
“Tharimmune Inc.”
全部
40,897
临床试验
11,201
药物
1,599
机构
6,168
资讯
21,929
去年
Tharimmune Stock Surges 60% Following FDA Fast-Track Designation and $5.47M Equity Raise
去年
Pharma Update: FDA Eases CGT Path, Tharimmune Surges on EMA Feedback, Lexeo Dips on Alzheimer's Data
去年
EMA Endorses Tharimmune's TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis
去年
Tharimmune's TH104 Advances to Phase 2 for Pruritus in Primary Biliary Cholangitis
去年
Tharimmune's TH104 Receives Positive EMA Feedback for Pruritus in Primary Biliary Cholangitis
去年
FDA Clears Expedited Pathway for Tharimmune's TH104 Opioid Defense Drug Without Additional Clinical Trials
去年
Tharimmune Reports Breakthrough in Oral Delivery of TNF-α Inhibitor for Inflammatory Diseases
去年
Tharimmune Advances TH104 as National Security Solution Against Weaponized Fentanyl, Secures $5.47M Funding
去年
Tharimmune Raises $1.74 Million to Advance Immunology and Oncology Pipeline
去年
Tharimmune Appoints New CEO and Board Members to Advance Opioid Antagonist TH104 Development
第 1 页,共 2193 页
上一页
下一页